admin

/admin

About admin

This author has not yet filled in any details.
So far admin has created 15 blog entries.

GHIF Performance Highlighted by KfW Development Bank

  Independent Review of GHIF Suggests the Fund is Performing Against Original Impact Investment Objectives Innovative financing model shows promise for supporting global health research and development in a sustainable manner FRANKFURT - December 21, 2016 - In mid-2016, KfW Development Bank, an anchor investor in GHIF, commissioned an independent mid-term review of the fund's performance [...]

By | December 21st, 2016|Uncategorized|0 Comments

GHIF Presents at Priority Review Voucher Summit

Press Release ### Global Health Investment Fund Managing Partner Curt LaBelle Speaks at Priority Review Voucher Summit Panel presentation covers PRV program’s impact on neglected disease research   NEW YORK - November 3, 2016 - Curt LaBelle, MD, Managing Partner of the Global Health Investment Fund, led a panel discussion yesterday on the impact of [...]

By | November 3rd, 2016|Uncategorized|0 Comments

GHIF Invests $8 Million in Access Bio, Inc.

Press Release ### Global Health Investment Fund Purchases $8 Million of Convertible Notes Issued by Access Bio, Inc. Proceeds will finance the purchase and installation of new manufacturing equipment for Access Bio’s rapid diagnostic test products   NEW YORK--The Global Health Investment Fund (“GHIF”) is pleased to announce that it has invested $8 million in [...]

By | March 30th, 2016|Uncategorized|0 Comments

GHIF Makes $6 Million Loan to Atomo Diagnostics

Press Release ### Atomo Secures $6 Million from the Global Health Investment Fund The investment will support scale up of Atomo’s global health activities, focusing on continued rollout of its award winning AtomoRapid™ HIV test and launch of an affordable HIV self-test offering unmatched performance January 13, 2016 (SYDNEY and NEW YORK): The Global Health [...]

By | January 14th, 2016|Uncategorized|0 Comments

GHIF-Backed EuBiologics Earns WHO Endorsement for Euvichol

From the World Health Organization:   Cholera vaccine supply set to double, easing global shortage 8 January 2016 Globally, OCV production is low, with demands currently exceeding supply. Sudan and Haiti last year made requests to WHO for supplies of vaccines to conduct pre-emptive vaccination campaigns that could not be filled because of the global [...]

By | January 10th, 2016|Uncategorized|0 Comments

Press Release: GHIF Finances Registration of Moxidectin for Onchocerciasis

$10 Million Investment into the Registration of Moxidectin, an Important New Global Health Medicine for River Blindness If approved, moxidectin is expected to significantly accelerate the eradication of this terrible neglected disease March 8, 2015 (LONDON – UK): The Global Health Investment Fund (GHIF) and Medicines Development for Global Health (Medicines Development) announced today a [...]

By | March 8th, 2015|Uncategorized|0 Comments

Press Release: GHIF Leads $7.5 Million Investment in Korean Vaccine Manufacturer

Global Health Investment Fund Leads 7.5 Million USD Investment into EuBiologics to Catalyze Availability of Low-Cost Oral Cholera Vaccine for the World’s Poor  Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers  August 27, 2014 (SEOUL): Global Health [...]

By | August 27th, 2014|Uncategorized|0 Comments

Press Release: GHIF Purchases $8 Million Convertible Bond to Finance New TB Diagnostic

  Global Health Investment Fund Announcement of Collaborative Funding Agreement with Epistem PLC Investment will support the roll-out of Epistem's Genedrive® molecular diagnostic platform as the company's tuberculosis assay enters pivotal field trials in key developing world locations July 22, 2014 (LONDON): The Global Health Investment Fund I, LLC (GHIF), is pleased to announce today that it [...]

By | July 22nd, 2014|Uncategorized|0 Comments

Press Release: GHIF Announces Final Close

New Investment Fund Will Advance Late-Stage Vaccines and other Global Health Technologies JPMorgan Chase, the Bill & Melinda Gates Foundation and partners announce successful capital raise for first-of-its-kind investment product September 23, 2013 (NEW YORK): A new investment fund structured by JPMorgan Chase & Co. (NYSE: JPM) and the Bill & Melinda Gates Foundation will, [...]

By | December 23rd, 2013|Uncategorized|0 Comments

Praesent Et Urna Turpis

Quisque ligulas ipsum, euismod atras vulputate iltricies etri elit. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Nulla nunc dui, tristique in semper vel, congue sed ligula. Nam dolor ligula, faucibus id sodales in, auctor fringilla libero. Pellentesque pellentesque tempor tellus eget hendrerit. Morbi id aliquam ligula. Aliquam id dui [...]

By | July 31st, 2012|Creative, Design|0 Comments